Anlotinib Combined With Chemotherapy for Recurrence of Pulmonary Sarcomatoid Cancer Previously Surgically Treated: A Case Report and Literature Review

BACKGROUND: Pulmonary sarcomatoid cancer (PSC) is a very rare subtype of poorly differentiated non-small-lung-cancer (NSCLC) with very poor prognosis. To date, the optimal treatment for PSC has not been elucidated, and the efficacy of anlotinib in PSC has not been previously reported. CASE PRESENTAT...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jing, Liang, Hejun, He, Jian, Sui, Xin, Qin, Yanru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8144523/
https://www.ncbi.nlm.nih.gov/pubmed/34046343
http://dx.doi.org/10.3389/fonc.2021.639168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8144523/
https://www.ncbi.nlm.nih.gov/pubmed/34046343
http://dx.doi.org/10.3389/fonc.2021.639168

Ejemplares similares